Showing results (621-630 of 6,951) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|July 1, 1996
The effect of orlistat on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteersJ Zhi, A T Melia, R Guerciolini, et al.Journal of Clinical Pharmacology|September 1, 1995
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisC A Elder, M Moore, C T Chang, et al.Journal of Clinical Pharmacology|June 1, 1989
The effects of flurbiprofen, aspirin, cimetidine, and antacids on the gastric and duodenal mucosa of normal volunteers. An endoscopic and photographic studyH Friedman, C E Seckman, J H Schwartz, et al.Journal of Clinical Pharmacology|March 1, 1989
Comparative gastrointestinal blood loss associated with placebo, aspirin, and nabumetone as assessed by radiochromium (51Cr)A Lussier, A Davis, Y Lussier, et al.Journal of Clinical Pharmacology|September 1, 1989
Stevens-Johnson syndrome, respiratory distress and acute renal failure due to synergic bleomycin-cisplatin toxicityA Brodsky, I Aparici, C Argeri, et al.Journal of Clinical Pharmacology|December 7, 2016
Population Pharmacokinetics of Ceritinib in Adult Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma KinaseYing Hong, Vanessa Q Passos, Pai-Hsi Huang, et al.Journal of Clinical Pharmacology|December 8, 2016
Population Pharmacokinetics of Cefazolin in Serum and Adipose Tissue From Overweight and Obese Women Undergoing Cesarean DeliveryMordechai Grupper, Joseph L Kuti, Morgan L Swank, et al.Journal of Clinical Pharmacology|April 4, 2017
A Simulation Study to Compare the Treatment Effect of Tamoxifen by CYP2D6 Genotypes and Third-Generation Aromatase InhibitorsGwan Cheol Park, Jin-A Jung, Kyun-Seop Bae, et al.Journal of Clinical Pharmacology|April 4, 2017
Population Pharmacokinetics of Nusinersen in the Cerebral Spinal Fluid and Plasma of Pediatric Patients With Spinal Muscular Atrophy Following Intrathecal AdministrationsKenneth T Luu, Daniel A Norris, Rudy Gunawan, et al.Journal of Clinical Pharmacology|December 27, 2016
Pharmacokinetics of a Single Oral Dose of the MEK1/2 Inhibitor Selumetinib in Subjects With End-Stage Renal Disease or Varying Degrees of Hepatic Impairment Compared With Healthy SubjectsAngela W Dymond, Paul Martin, Karen So, et al.Pageof 696